Skip to main content

Table 2 pIC50 and maximum percentage of stimulation of proteasome inhibitors in different assays

From: Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials

Proteasome inhibitor

pIC50 reported whole cell

pIC50 AlphaLISA (n = 4)

Maximum% stimulation AlphaLISA

pIC50 DELFIA (n = 4)

Maximum% stimulation DELFIA

Epoxomicin

8.17

7.64 ± 0.09

178 ± 47

7.74 ± 0.24

177 ± 15

Bortezomib

7.05

7.95 ± 0.08

178 ± 24

8.16 ± 0.05

180 ± 14

Gliotoxin

5.66

5.88 ± 0.73

217 ± 53

6.12 ± 0.27

180 ± 26

MG132

7.65

7.17 ± 0.04

236 ± 36

7.41 ± 0.21

189 ± 55

MG115

7.01

6.88 ± 0.09

208 ± 22

6.92 ± 0.21

185 ± 17

Lactacystin

5.83

5.81 ± 0.07

217 ± 27

6.06 ± 0.22

193 ± 32

Clasto-lactacystin β lactone

5.83

6.30 ± 0.09

195 ± 19

6.48 ± 0.18

198 ± 17